Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
David R. Sullivan
Based on 10 articles published since 2010
(Why 10 articles?)
||||
Expertise Level
The expertise of David R. Sullivan ranks in the
  • Top 0.43%
  • ... of 32,141 published authors worldwide on Hypercholesterolemia
  • ... from 2010 through 2020
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Sullivan, David   ·   Sullivan, David R
Work Locations
Details
Most likely:    Miscellaneous institutions in Sydney      
2018
  • Department of Vascular Medicine, Academic Medical Center of Amsterdam, Amsterdam, Netherlands. · Departments of Epidemiology and Medicine, University of Iowa, Iowa City, Iowa. · Department of Medicine, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa. · Institut de recherches cliniques de Montréal, Université de Montréal, Montreal, Canada. · Department of Clinical Biochemistry, Prince Alfred Hospital, Camperdown, Australia. · Amgen Inc., Thousand Oaks, California. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Pubmed 30120772
Probable:    Royal Prince Alfred Hospital      
2017
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, The Netherlands. Electronic address: · Faculty of Health Sciences, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa. · Clinical Development Department, Amgen (Europe) GmbH, Zug, Switzerland. · Department of Molecular Medicine, Umberto I Hospital, Sapienza University of Rome, Rome, Italy. · Centres Hospitaliers Jolimont, Lipid Clinic, Haine-Saint-Paul, Belgium. · Internal Medicine Department, Hospital Universitari Sant Joan, Lipids and Arteriosclerosis Research Unit, Universitat Rovira i Virgili, IISPV, CIBERDEM, Reus, Spain. · Clinical Development Department, Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, USA. · Biostatistics Department, Amgen Ltd, Cambridge, United Kingdom. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 29066265
2016
  • Preventive Cardiology and Rehabilitation, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Wesley Medical Centre, 40 Chasely Street, Auchenflower, Brisbane, 4066, QLD, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Building 65 Missenden Road, Camperdown, NSW, Australia. · Cardiometabolic Disorders, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, Box 1030, New York, NY, 10029, USA. · Amgen (Europe) GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. · Department of Vascular Medicine, F4.211, Academic Medical Center, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. · Pubmed 26936841
2015
  • School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia. · Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, New South Wales, Australia. · Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. · Department of Cardiovascular Medicine, Yonghe Cardinal Tien Hospital, Fu Jen Catholic University, New Taipei City, Taiwan. · Genzyme, A Sanofi Company, Cambridge, MA, USA. · School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, Western Australia, Australia. Electronic address: · Pubmed 25670359
2014
  • Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, The University of Western Australia, GPO Box X2213, Perth, WA 6847, Australia. Electronic address: · Cardiology Division, Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE, USA; Jefferson Medical College, Philadelphia, PA, USA. · Department of Metabolic Medicine and Chemical Pathology, Guy's & St Thomas Hospitals, NHS Foundation Trust, London, UK. · CGH Medical Centre, Sterling, IL, USA; University of Illinois College of Medicine, Peoria, IL, USA; Illinois Michigan State University College of Osteopathic Medicine, East Lansing, MI, USA. · Lipid Clinic, Department of Internal Medicine, Fundacion Jimenez Diaz, Madrid, Spain. · Emory University School of Medicine, Emory University, Atlanta, GA, USA. · Department of Endocrinology and Prevention of Cardiovascular Disease, Hôpital Pitié-Salpêtrière, University of Paris VI, Paris, France. · Laboratory for Experimental Vascular Medicine, Section of Molecular Diagnostics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pontai Medical Centre, Heart Foundation of Malaysia, Kuala Lumpur, Malaysia. · The International FH Foundation, St Andrews Court, Thame, Oxfordshire, UK. · Fundacion Hipercolesterolemia Familiar, Madrid, Spain. · Medical Department 2, Division of Metabolism and Endocrinology, Ludwig- Maximilians-University of Munich, Munich, Germany. · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School, University of Sao Paulo, Sao Paulo, Brazil. · Section of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands. · Department of Clinical Biochemistry, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, Scotland. · Lipid Clinic and Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia. · Laboratory of Clinical Lipidology, Department of Atherosclerosis, Cardiology Research Complex, Ministry of Health of Russian Federation, Moscow, Russia. · Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, The People's Republic of China. · Department of Paediatrics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Department of Community Medicine and Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan. · Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pubmed 24636175
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Wesley Medical Centre, Auchenflower, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Hospital Universitario Miguel Servet, Zaragoza, Spain. · Cardiometabolic Disorders Department, Icahn School of Medicine at Mount Sinai, New York, New York. · Lipid Disorders Clinic, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Hopital Pitie-Salpetriere, Paris, France. · Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, Ohio. · Amgen, Thousand Oaks, California. · Cardiovascular Medicine Department, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24694531
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2012
  • Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Pubmed 23128163
Probable:    University of Sydney      
2015
  • School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia. · Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, New South Wales, Australia. · Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. · Department of Cardiovascular Medicine, Yonghe Cardinal Tien Hospital, Fu Jen Catholic University, New Taipei City, Taiwan. · Genzyme, A Sanofi Company, Cambridge, MA, USA. · School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, Western Australia, Australia. Electronic address: · Pubmed 25670359
2014
  • Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, The University of Western Australia, GPO Box X2213, Perth, WA 6847, Australia. Electronic address: · Cardiology Division, Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE, USA; Jefferson Medical College, Philadelphia, PA, USA. · Department of Metabolic Medicine and Chemical Pathology, Guy's & St Thomas Hospitals, NHS Foundation Trust, London, UK. · CGH Medical Centre, Sterling, IL, USA; University of Illinois College of Medicine, Peoria, IL, USA; Illinois Michigan State University College of Osteopathic Medicine, East Lansing, MI, USA. · Lipid Clinic, Department of Internal Medicine, Fundacion Jimenez Diaz, Madrid, Spain. · Emory University School of Medicine, Emory University, Atlanta, GA, USA. · Department of Endocrinology and Prevention of Cardiovascular Disease, Hôpital Pitié-Salpêtrière, University of Paris VI, Paris, France. · Laboratory for Experimental Vascular Medicine, Section of Molecular Diagnostics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pontai Medical Centre, Heart Foundation of Malaysia, Kuala Lumpur, Malaysia. · The International FH Foundation, St Andrews Court, Thame, Oxfordshire, UK. · Fundacion Hipercolesterolemia Familiar, Madrid, Spain. · Medical Department 2, Division of Metabolism and Endocrinology, Ludwig- Maximilians-University of Munich, Munich, Germany. · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School, University of Sao Paulo, Sao Paulo, Brazil. · Section of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands. · Department of Clinical Biochemistry, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, Scotland. · Lipid Clinic and Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia. · Laboratory of Clinical Lipidology, Department of Atherosclerosis, Cardiology Research Complex, Ministry of Health of Russian Federation, Moscow, Russia. · Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, The People's Republic of China. · Department of Paediatrics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Department of Community Medicine and Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan. · Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pubmed 24636175
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by David R. Sullivan in 2010-2020 about Hypercholesterolemia:

  • Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies. 2018
  • Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia. 2017
  • Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study. 2016
  • Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: a pilot study. 2015
  • Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. 2014
  • Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab. 2014
  • Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy. 2014
  • Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. 2014
  • Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial. 2012
  • Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. 2010
Show List of Full Article Records
Google Searches

Learn more about David R. Sullivan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Sydney
Royal Prince Alfred Hospital
University of Sydney
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Sydney
2018
  • Department of Vascular Medicine, Academic Medical Center of Amsterdam, Amsterdam, Netherlands. · Departments of Epidemiology and Medicine, University of Iowa, Iowa City, Iowa. · Department of Medicine, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa. · Institut de recherches cliniques de Montréal, Université de Montréal, Montreal, Canada. · Department of Clinical Biochemistry, Prince Alfred Hospital, Camperdown, Australia. · Amgen Inc., Thousand Oaks, California. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Pubmed 30120772
Royal Prince Alfred Hospital
2017
  • Department of Vascular Medicine, Academisch Medisch Centrum, Amsterdam, The Netherlands. Electronic address: · Faculty of Health Sciences, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa. · Clinical Development Department, Amgen (Europe) GmbH, Zug, Switzerland. · Department of Molecular Medicine, Umberto I Hospital, Sapienza University of Rome, Rome, Italy. · Centres Hospitaliers Jolimont, Lipid Clinic, Haine-Saint-Paul, Belgium. · Internal Medicine Department, Hospital Universitari Sant Joan, Lipids and Arteriosclerosis Research Unit, Universitat Rovira i Virgili, IISPV, CIBERDEM, Reus, Spain. · Clinical Development Department, Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, USA. · Biostatistics Department, Amgen Ltd, Cambridge, United Kingdom. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 29066265
2016
  • Preventive Cardiology and Rehabilitation, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Wesley Medical Centre, 40 Chasely Street, Auchenflower, Brisbane, 4066, QLD, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Building 65 Missenden Road, Camperdown, NSW, Australia. · Cardiometabolic Disorders, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, Box 1030, New York, NY, 10029, USA. · Amgen (Europe) GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. · Department of Vascular Medicine, F4.211, Academic Medical Center, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. · Pubmed 26936841
2015
  • School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia. · Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, New South Wales, Australia. · Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. · Department of Cardiovascular Medicine, Yonghe Cardinal Tien Hospital, Fu Jen Catholic University, New Taipei City, Taiwan. · Genzyme, A Sanofi Company, Cambridge, MA, USA. · School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, Western Australia, Australia. Electronic address: · Pubmed 25670359
2014
  • Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, The University of Western Australia, GPO Box X2213, Perth, WA 6847, Australia. Electronic address: · Cardiology Division, Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE, USA; Jefferson Medical College, Philadelphia, PA, USA. · Department of Metabolic Medicine and Chemical Pathology, Guy's & St Thomas Hospitals, NHS Foundation Trust, London, UK. · CGH Medical Centre, Sterling, IL, USA; University of Illinois College of Medicine, Peoria, IL, USA; Illinois Michigan State University College of Osteopathic Medicine, East Lansing, MI, USA. · Lipid Clinic, Department of Internal Medicine, Fundacion Jimenez Diaz, Madrid, Spain. · Emory University School of Medicine, Emory University, Atlanta, GA, USA. · Department of Endocrinology and Prevention of Cardiovascular Disease, Hôpital Pitié-Salpêtrière, University of Paris VI, Paris, France. · Laboratory for Experimental Vascular Medicine, Section of Molecular Diagnostics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pontai Medical Centre, Heart Foundation of Malaysia, Kuala Lumpur, Malaysia. · The International FH Foundation, St Andrews Court, Thame, Oxfordshire, UK. · Fundacion Hipercolesterolemia Familiar, Madrid, Spain. · Medical Department 2, Division of Metabolism and Endocrinology, Ludwig- Maximilians-University of Munich, Munich, Germany. · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School, University of Sao Paulo, Sao Paulo, Brazil. · Section of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands. · Department of Clinical Biochemistry, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, Scotland. · Lipid Clinic and Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia. · Laboratory of Clinical Lipidology, Department of Atherosclerosis, Cardiology Research Complex, Ministry of Health of Russian Federation, Moscow, Russia. · Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, The People's Republic of China. · Department of Paediatrics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Department of Community Medicine and Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan. · Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pubmed 24636175
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Wesley Medical Centre, Auchenflower, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Hospital Universitario Miguel Servet, Zaragoza, Spain. · Cardiometabolic Disorders Department, Icahn School of Medicine at Mount Sinai, New York, New York. · Lipid Disorders Clinic, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Hopital Pitie-Salpetriere, Paris, France. · Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, Ohio. · Amgen, Thousand Oaks, California. · Cardiovascular Medicine Department, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24694531
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2012
  • Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Pubmed 23128163
University of Sydney
2015
  • School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia. · Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, New South Wales, Australia. · Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. · Department of Cardiovascular Medicine, Yonghe Cardinal Tien Hospital, Fu Jen Catholic University, New Taipei City, Taiwan. · Genzyme, A Sanofi Company, Cambridge, MA, USA. · School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, Western Australia, Australia. Electronic address: · Pubmed 25670359
2014
  • Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, The University of Western Australia, GPO Box X2213, Perth, WA 6847, Australia. Electronic address: · Cardiology Division, Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE, USA; Jefferson Medical College, Philadelphia, PA, USA. · Department of Metabolic Medicine and Chemical Pathology, Guy's & St Thomas Hospitals, NHS Foundation Trust, London, UK. · CGH Medical Centre, Sterling, IL, USA; University of Illinois College of Medicine, Peoria, IL, USA; Illinois Michigan State University College of Osteopathic Medicine, East Lansing, MI, USA. · Lipid Clinic, Department of Internal Medicine, Fundacion Jimenez Diaz, Madrid, Spain. · Emory University School of Medicine, Emory University, Atlanta, GA, USA. · Department of Endocrinology and Prevention of Cardiovascular Disease, Hôpital Pitié-Salpêtrière, University of Paris VI, Paris, France. · Laboratory for Experimental Vascular Medicine, Section of Molecular Diagnostics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pontai Medical Centre, Heart Foundation of Malaysia, Kuala Lumpur, Malaysia. · The International FH Foundation, St Andrews Court, Thame, Oxfordshire, UK. · Fundacion Hipercolesterolemia Familiar, Madrid, Spain. · Medical Department 2, Division of Metabolism and Endocrinology, Ludwig- Maximilians-University of Munich, Munich, Germany. · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School, University of Sao Paulo, Sao Paulo, Brazil. · Section of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands. · Department of Clinical Biochemistry, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, Scotland. · Lipid Clinic and Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia. · Laboratory of Clinical Lipidology, Department of Atherosclerosis, Cardiology Research Complex, Ministry of Health of Russian Federation, Moscow, Russia. · Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, The People's Republic of China. · Department of Paediatrics, Academic Medical Centre, University of Amsterdam, The Netherlands. · Department of Community Medicine and Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan. · Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands. · Pubmed 24636175
Cleveland Clinic
2014
  • Department of Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24477778
George Institute for Global Health
2010
  • The George Institute for International Health, Sydney, Australia. · Pubmed 20837464
Yearly article counts 00111140101
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.